Cover Image
市場調查報告書

Nerviano Medical Sciences S.r.l.:產品平台分析

Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 342295
出版日期 內容資訊 英文 46 Pages
訂單完成後即時交付
價格
Back to Top
Nerviano Medical Sciences S.r.l.:產品平台分析 Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2015
出版日期: 2015年09月16日 內容資訊: 英文 46 Pages
簡介

Nerviano Medical Sciences是專門進行新抗癌劑的發明及開發的研究開發企業,與生物醫藥品企業合作,正在開發各種抗癌藥。

本報告提供Nerviano Medical Sciences公司的開發平台趨勢相關調查,提供您企業資料,R&D的配合措施,開發平台的現狀與各開發階段分析,並彙整藥物簡介,最新的企業新聞和發表等資料。

Nerviano Medical Sciences的基本資料

  • 概要
  • 主要資訊
  • 企業資料

Nerviano Medical Sciences:R&D概要

  • 主要的治療範圍

Nerviano Medical Sciences:開發平台評估

  • 開發中產品:各開發階段
  • 開發中產品:單劑產品
  • 開發中產品:聯盟產品
    • 聯盟產品/聯合治療模式
  • 開發中產品:轉出授權產品
    • 轉出授權產品/聯合治療模式

Nerviano Medical Sciences:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Nerviano Medical Sciences:藥物簡介

  • 癌症的單株抗體konjugeto
  • NMS-616
  • NMSE-973
  • NMSP-088
  • NMSP-118
  • NMSP-153
  • NMSP-285
  • NMSP-626
  • NMSP-648
  • NMSP-715
  • NMSP-914
  • NMSP-953
  • PNU-159682
  • 卵巢癌的Hsp90阻礙小分子
  • 癌症的蛋白激梅阻礙小分子
  • NMS-873
  • 癌症的Pim激梅阻礙小分子
    • 產品概要
    • 作用機制
    • R&D的進展

Nerviano Medical Sciences:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Nerviano Medical Sciences:最近的開發平台趨勢

Nerviano Medical Sciences:暫停中的計劃

Nerviano Medical Sciences:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC07578CDB

Summary

Global Markets Direct's, 'Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2015', provides an overview of the Nerviano Medical Sciences S.r.l.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nerviano Medical Sciences S.r.l.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Nerviano Medical Sciences S.r.l. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Nerviano Medical Sciences S.r.l.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Nerviano Medical Sciences S.r.l.'s pipeline products

Reasons to buy

  • Evaluate Nerviano Medical Sciences S.r.l.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Nerviano Medical Sciences S.r.l. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences S.r.l.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Nerviano Medical Sciences S.r.l. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nerviano Medical Sciences S.r.l.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Nerviano Medical Sciences S.r.l. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Nerviano Medical Sciences S.r.l. Snapshot
    • Nerviano Medical Sciences S.r.l. Overview
    • Key Information
    • Key Facts
  • Nerviano Medical Sciences S.r.l. - Research and Development Overview
    • Key Therapeutic Areas
  • Nerviano Medical Sciences S.r.l. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Nerviano Medical Sciences S.r.l. - Pipeline Products Glance
    • Nerviano Medical Sciences S.r.l. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Nerviano Medical Sciences S.r.l. - Drug Profiles
    • Monoclonal Antibody Conjugate for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-616
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSE-973
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-088
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-118
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-153
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-285
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-626
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-648
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-715
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-914
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSP-953
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNU-159682
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Hsp90 for Ovarian Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Protein Kinase for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-873
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Pim Kinase for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Nerviano Medical Sciences S.r.l. - Pipeline Analysis
    • Nerviano Medical Sciences S.r.l. - Pipeline Products by Target
    • Nerviano Medical Sciences S.r.l. - Pipeline Products by Route of Administration
    • Nerviano Medical Sciences S.r.l. - Pipeline Products by Molecule Type
    • Nerviano Medical Sciences S.r.l. - Pipeline Products by Mechanism of Action
  • Nerviano Medical Sciences S.r.l. - Recent Pipeline Updates
  • Nerviano Medical Sciences S.r.l. - Dormant Projects
  • Nerviano Medical Sciences S.r.l. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Nerviano Medical Sciences S.r.l., Key Information
  • Nerviano Medical Sciences S.r.l., Key Facts
  • Nerviano Medical Sciences S.r.l. - Pipeline by Indication, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline by Stage of Development, 2015
  • Nerviano Medical Sciences S.r.l. - Monotherapy Products in Pipeline, 2015
  • Nerviano Medical Sciences S.r.l. - Partnered Products in Pipeline, 2015
  • Nerviano Medical Sciences S.r.l. - Partnered Products/ Combination Treatment Modalities, 2015
  • Nerviano Medical Sciences S.r.l. - Out-Licensed Products in Pipeline, 2015
  • Nerviano Medical Sciences S.r.l. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Nerviano Medical Sciences S.r.l. - Preclinical, 2015
  • Nerviano Medical Sciences S.r.l. - Discovery, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline by Target, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline by Route of Administration, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline by Molecule Type, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline Products by Mechanism of Action, 2015
  • Nerviano Medical Sciences S.r.l. - Recent Pipeline Updates, 2015
  • Nerviano Medical Sciences S.r.l. - Dormant Developmental Projects,2015

List of Figures

  • Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Indication, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline by Stage of Development, 2015
  • Nerviano Medical Sciences S.r.l. - Monotherapy Products in Pipeline, 2015
  • Nerviano Medical Sciences S.r.l. - Out-Licensed Products in Pipeline, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Target, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline by Top 10 Molecule Type, 2015
  • Nerviano Medical Sciences S.r.l. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top